Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Oct 16:11:582891.
doi: 10.3389/fneur.2020.582891. eCollection 2020.

Prediction of Neurodevelopment in Infants With Tuberous Sclerosis Complex Using Early EEG Characteristics

Affiliations

Prediction of Neurodevelopment in Infants With Tuberous Sclerosis Complex Using Early EEG Characteristics

Jessie De Ridder et al. Front Neurol. .

Abstract

Tuberous Sclerosis Complex (TSC) is a multisystem genetic disorder with a high risk of early-onset epilepsy and a high prevalence of neurodevelopmental comorbidities, including intellectual disability and autism spectrum disorder (ASD). Therefore, TSC is an interesting disease model to investigate early biomarkers of neurodevelopmental comorbidities when interventions are favourable. We investigated whether early EEG characteristics can be used to predict neurodevelopment in infants with TSC. The first recorded EEG of 64 infants with TSC, enrolled in the international prospective EPISTOP trial (recorded at a median gestational age 42 4/7 weeks) was first visually assessed. EEG characteristics were correlated with ASD risk based on the ADOS-2 score, and cognitive, language, and motor developmental quotients (Bayley Scales of Infant and Toddler Development III) at the age of 24 months. Quantitative EEG analysis was used to validate the relationship between EEG background abnormalities and ASD risk. An abnormal first EEG (OR = 4.1, p-value = 0.027) and more specifically a dysmature EEG background (OR = 4.6, p-value = 0.017) was associated with a higher probability of ASD traits at the age of 24 months. This association between an early abnormal EEG and ASD risk remained significant in a multivariable model, adjusting for mutation and treatment (adjusted OR = 4.2, p-value = 0.029). A dysmature EEG background was also associated with lower cognitive (p-value = 0.029), language (p-value = 0.001), and motor (p-value = 0.017) developmental quotients at the age of 24 months. Our findings suggest that early EEG characteristics in newborns and infants with TSC can be used to predict neurodevelopmental comorbidities.

Keywords: EEG; TAND profile; autism (ASD); biomarker; neurodeveloment; tuberous sclerosis complex (TSC).

PubMed Disclaimer

Figures

Figure 1
Figure 1
Overview of EEG characteristics and neurodevelopmental outcome at the age of 24 months. (A) Autism spectrum disorder by EEG abnormalities. (B) Cognitive, language and motor developmental quotients based on Bayley Scales of Infant and Toddler Development -III test results. *p-value < 0.05, **p-value < 0.01. A red line indicates significance in a multivariable model.
Figure 2
Figure 2
Quantitative EEG features of TSC patients with and without ASD at the age of 24 months. The figure shows the entropy at scale 20 [MSE(20)] (A) Hurst Exponent (B) and the asymmetry of the range EEG (C) (estimate of amplitude integrated EEG) in two groups (no ASD vs. ASD at 24 months). The EEGs of patients with ASD at 24 months show a more asymmetric range EEG, a higher Hurst Exponent (more regularity) and lower entropy at lower frequencies [MSE(20)] (less complexity). In (A,B), the comparisons are reported for each EEG channel. In (C), the comparisons are reported for the frequency bands. P-values have been derived by Kruskal-Wallis test.

References

    1. Curatolo P, Moavero R, de Vries PJ. Neurological and neuropsychiatric aspects of tuberous sclerosis complex. Lancet Neurol. (2015) 14:733–45. 10.1016/S1474-4422(15)00069-1 - DOI - PubMed
    1. Henske EP, Jóźwiak S, Kingswood JC, Sampson JR, Thiele EA. Tuberous sclerosis complex. Nat Rev Dis Primers. (2016) 2:16035 10.1038/nrdp.2016.35 - DOI - PubMed
    1. Curatolo P. Mechanistic target of rapamycin (mTOR) in tuberous sclerosis complex-associated epilepsy. Pediatr Neurol. (2015) 52:281–9. 10.1016/j.pediatrneurol.2014.10.028 - DOI - PubMed
    1. Chu-Shore CJ, Major P, Camposano S, Muzykewicz D, Thiele EA. The natural history of epilepsy in tuberous sclerosis complex. Epilepsia. (2010) 51:1236–41. 10.1111/j.1528-1167.2009.02474.x - DOI - PMC - PubMed
    1. Kotulska K, Jurkiewicz E, Domanska-Pakiela D, Grajkowska W, Mandera M, Borkowska J, et al. Epilepsy in newborns with tuberous sclerosis complex. Eur J Paediatr Neurol. (2014) 18:714–21. 10.1016/j.ejpn.2014.06.009 - DOI - PubMed

LinkOut - more resources